AGENT "LIZOLAKT" POTENTIATING ANTITUMOR ACTIVITY OF CYTOTOXIC PREPARATIONS Russian patent published in 2007 - IPC A61K38/46 A61K31/7016 A61P35/00 A61P37/02 

FIELD: medicine, food industry.

SUBSTANCE: invention relates to an agent potentiating the antitumor activity of cytotoxic preparations and comprising lysozyme (lysozyme chloride, lysozyme hydrochloride) in the amount 0.5-2.0 g and, additionally, lactulose in the amount 2.5-10.0 g in a single dose. Using the claimed agent provides enhancing effectiveness in treatment of oncological patients, accelerating remission onset, increasing remission period, decreasing frequency of oncological disease relapse, improving tolerance of polychemotherapy, reducing frequency and severity in course of hospital infection, disbiotic, infectious, destructive, hemorrhagic and other complications in carrying out cytostatic therapy, enhancing effectiveness of antibiotics in treatment of infectious-inflammatory complications in oncological patients and decreasing consumptions in treatment of oncological patients. Invention can be used in oncology as a biologically active supplement to curative nutrition in complex treatment of leucosis and other tumors.

EFFECT: enhanced medicinal effectiveness of agent.

3 cl, 2 tbl, 2 ex